Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma

Annals of Surgical Oncology

Volumn 20, Issue 13, 2013, Pages 4389-4396

  Sakano, Shigeru ^a   Matsuyama, Hideyasu ^a   Kamiryo, Yoriaki ^b   Hayashida, Shigeaki ^c   Yamamoto, Norio ^d   Kaneda, Yoshitaka ^e   Nasu, Takahito ^c   Hashimoto, Osamu ^f   Joko, Keiji ^g   Baba, Yoshikazu ^h   Shimabukuro, Tomoyuki ⁱ   Suga, Akinobu ^j   Yamamoto, Mitsutaka ^k   Aoki, Akihiko ^l   Takai, Kimio ^m   Yoshihiro, Satoru ⁿ   Matsumura, Masafumi ^k  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Urology   (Japan)

^c Tokuyama Central Hospital   (Japan)

^d Tokuyama Hospital   (Japan)

^e Department of Urology   (Japan)

^f Ogori Daiichi General Hospital   (Japan)

^g Yamaguchi Saiseikai General Hospital   (Japan)

^h Shuto General Hospital   (Japan)

ⁱ UBE INDUSTRIES LTD   (Japan)

^j YAMAGUCHI RED CROSS HOSPITAL   (Japan)

^k Yamaguchi Grand Medical Center   (Japan)

^l Masuda Red Cross Hospital   (Japan)

^m Saiseikai Shimonoseki General Hospital   (Japan)

ⁿ Shimonoseki City Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYDRONEPHROSIS; LABORATORY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROURETERECTOMY; PREOPERATIVE PERIOD; RADICAL RESECTION; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; UPPER URINARY TRACT UROTHELIAL CARCINOMA; URINE CYTOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS;

EID: 84892373330     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3259-0     Document Type: Article

References (26)

1. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584-94
2. Zigeuner R, Pummer K. Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol. 2008;53:720-31
3. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224-33
4. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612-8
5. Ito Y, Kikuchi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2011;185:1621-6
6. Colin P, Ouzzane A, Yates DR, et al. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol. 2012;19:3613-20
7. Hellenthal NJ, Shariat SF, Margulis V, et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol. 2009;182:900-6
8. Kaag MG, O'Malley RL, O'Malley P, et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010;58:581-7
9. Matin SF, Margulis V, Kamat A, et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for highrisk upper tract transitional cell carcinoma. Cancer. 2010;116: 3127-34
10. Collaboration ABCAM-a. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Metaanalysis Collaboration. Eur Urol. 2005;48:189-99
11. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349: 859-66
12. Griffiths G, Hall R, Sylvester R, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol. 2011;29:2171-7
13. Margulis V, Youssef RF, Karakiewicz PI, et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010;184:453-8
14. Lehmann J, Suttmann H, Kovac I, et al. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol. 2007;51:1281-8
15. Brien JC, Shariat SF, Herman MP, et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 2010;184:69-73
16. Favaretto RL, Shariat SF, Savage C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2012;109:77-82
17. Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100-14
18. Orrell DH. Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta. 1971;35:483-9
19. Lehmann J, Retz M, Nurnberg N, et al. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma. Cancer. 2004;101:1552-62
20. Scolieri MJ, Paik ML, Brown SL, et al. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology. 2000;56:930-4
21. Brown GA, Matin SF, Busby JE, et al. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007;70: 252-6
22. Smith AK, Stephenson AJ, Lane BR, et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82-6
23. Williams SK, Denton KJ, Minervini A, et al. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol. 2008;22:71-6
24. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7
25. Saito K, Kawakami S, Ohtsuka Y, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007;100:269-73
26. Suttmann H, Kamradt J, Lehmann J, Stockle M. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy. BJU Int. 2007;100:1225-8.